DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ. et al.
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): A multicentre, randomised, open-label, phase 3 trial.

Lancet Oncol 2019;
20: 924-37

Download Bibliographical Data

Access:
Access: